Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs34350562 | chr7:128718708 | A/G | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs34381587 | chr7:128666825 | A/G | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs34394180 | chr6:42660885 | TC/T | 2.89E-8 | 133 | 37.95 | 47.52 | 20.6 | KM Plot |
| TGCT | rs34403046 | chr8:103084305 | TA/T | 0.00011 | 134 | 42.27 | 28.27 | 48.45 | KM Plot |
| TGCT | rs34403732 | chr3:172486597 | T/A | 5.36E-5 | 132 | 42.1 | 46.3 | 47.38 | KM Plot |
| TGCT | rs34448879 | chr12:129265792 | C/T | 2.19E-5 | 130 | 45.1 | 42.27 | 21.75 | KM Plot |
| TGCT | rs34544855 | chr10:27586258 | C/T | 0 | 127 | 42.18 | 45.83 | 18.85 | KM Plot |
| TGCT | rs34591253 | chr7:128721877 | C/T | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs34628732 | chr3:172479150 | A/G | 5.36E-5 | 133 | 42.1 | 41.92 | 47.38 | KM Plot |
| TGCT | rs34644138 | chr7:128720967 | A/G | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs34725944 | chr7:128641653 | T/C | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs34748780 | chr7:128700153 | A/G | 1.87E-5 | 133 | 42.18 | 30.3 | 17.1 | KM Plot |
| TGCT | rs34865778 | chr7:128717305 | G/A | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs34871361 | chr7:128671086 | C/T | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs34888374 | chr12:129296536 | G/A | 1.39E-5 | 134 | 41.33 | 44.28 | 29.53 | KM Plot |